Posted in | News | Biosensors

USPTO Issues Notice of Allowance for VerifyMe’s New New Biometrics Patent

VerifyMe, Inc., a pioneer in patented physical, cyber and biometric technology solutions that prevent identity theft, counterfeiting and fraud, announced today that it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application U.S. 13/910,482 titled “‘Home’ Button With Integrated User Biometric Sensing and Verification System for a Mobile Device.”

“This patent is the latest addition to our portfolio of technology that enables our clients to protect their brands and their consumers,” commented Sandy Fliderman, VerifyMe’s Chief Technology Officer and co-inventor of this patent. “We also have numerous patent applications pending with USPTO, and this favorable review underscores the ingenuity of our technologies and the solutions we deliver.”

The patent covers the ability to use an optical sensor/scanner under the home button of a mobile (and other) device to verify the authenticity of the user and make available access to some or all of the contents of the device.

VerifyMe’s patents for digital solutions include 3+ factor replacements for passwords, pins and tokens. Based on sophisticated risk scoring and adaptive authentication, the VerifyMe solutions incorporate many dimensions, including biometrics such as facial, gesture, voice and fingerprint recognition.

VerifyMe’s patents for physical solutions include authentication solutions that can be verified by the end-user/consumer with no specialized equipment, in addition to multiple levels of forensic inspection.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.